Regeneron Pharmaceuticals Stock Price - REGN

0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.74 0.19% 399.55 393.3913 402.09 399.10 398.81 23:59:40
Bid Price Ask Price Spread Spread % News
388.00 425.00 37.00 8.71% 4 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,302 536,829 $ 400.25 $ 214,865,689 861,855 271.37 - 445.00
Last Trade Time Type Quantity Stock Price Currency
16:47:41 formt 8,264 $ 399.55 USD

Regeneron Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 43.96B 110.02M $ 2.44B 18.45 21.60 108.28M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Regeneron Pharmaceuticals News

Date Time Source News Article
2/14/202017:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/14/202016:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/14/202016:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
2/14/202006:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/12/202016:01PR Newswire (US)Regeneron Announces Upcoming Investor Conference..
2/12/202011:18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/10/202016:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)

Latest REGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical REGN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week391.07413.64376.01393.39949,3818.482.17%
1 Month387.00413.64328.125367.40970,79012.553.24%
3 Months350.93413.64328.125370.63778,67848.6213.85%
6 Months301.83413.64271.37335.57737,06097.7232.38%
1 Year412.00445.00271.37338.52753,439-12.45-3.02%
3 Years375.95543.5518271.37373.13795,91723.606.28%
5 Years402.00605.9299271.37398.83793,167-2.45-0.61%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.
Your Recent History
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200217 04:47:41